Profile data is unavailable for this security.
About the company
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
- Revenue in USD (TTM)311.00k
- Net income in USD-12.39m
- Incorporated2000
- Employees16.00
- LocationNotable Labs Ltd320 Hatch DriveFOSTER CITY 94404United StatesUSA
- Phone+1 (415) 851-2410
- Fax+972 8993-5001
- Websitehttps://notablelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NLS Pharmaceutics AG | 0.00 | -12.17m | 6.86m | 3.00 | -- | -- | -- | -- | -0.3188 | -0.3188 | 0.00 | -0.2724 | 0.00 | -- | -- | 0.00 | -218.86 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -81.34 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
Scorpius Holdings Inc | 2.23m | -46.05m | 6.86m | 77.00 | -- | 0.0749 | -- | 3.08 | -1.78 | -2.00 | 0.0859 | 1.39 | 0.0234 | -- | 0.6762 | 28,918.57 | -50.05 | -38.42 | -61.25 | -42.06 | 29.10 | -- | -2,136.28 | -703.02 | -- | -- | 0.2305 | -- | 202.12 | 33.24 | -23.85 | -- | 218.50 | -- |
Cell MedX Corp | 70.00 | -96.91k | 6.90m | 0.00 | -- | -- | -- | 98,512.63 | -0.0029 | -0.0029 | 0.00 | -0.0024 | 0.0015 | -- | -- | -- | -202.28 | -792.55 | -- | -- | -685.71 | -- | -138,442.90 | -3,681.84 | -- | -3.17 | -- | -- | -54.53 | -- | 29.01 | -- | -- | -- |
Tenax Therapeutics Inc | 0.00 | -10.10m | 6.97m | 5.00 | -- | 0.5609 | -- | -- | -24.52 | -24.52 | 0.00 | 6.35 | 0.00 | -- | -- | 0.00 | -67.96 | -199.16 | -75.66 | -285.64 | -- | -- | -- | -- | -- | -105.12 | 0.0322 | -- | -- | -- | 30.21 | -- | -- | -- |
Longeveron Inc | 978.00k | -21.62m | 7.11m | 23.00 | -- | 0.9275 | -- | 7.27 | -9.58 | -9.58 | 0.4297 | 1.21 | 0.0621 | -- | 7.14 | 42,521.74 | -132.19 | -63.15 | -184.16 | -75.68 | 48.47 | 33.70 | -2,129.24 | -441.02 | -- | -- | 0.00 | -- | -41.98 | -19.78 | -17.92 | -- | 26.80 | -- |
Kazia Therapeutics Ltd (ADR) | 14.90k | -13.52m | 7.12m | 12.00 | -- | 0.7734 | -- | 477.59 | -0.82 | -0.82 | 0.0008 | 0.3491 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
Pulmatrix Inc | 11.68m | -8.85m | 7.16m | 22.00 | -- | 0.3764 | -- | 0.6127 | -2.42 | -2.42 | 3.20 | 5.21 | 0.3517 | -- | 17.84 | 531,090.90 | -26.63 | -46.91 | -30.21 | -58.12 | -- | -- | -75.73 | -238.04 | -- | -- | 0.00 | -- | 20.21 | 116.62 | 25.03 | -- | 104.29 | -- |
Shuttle Pharmaceuticals Holdings Inc | 0.00 | -6.59m | 7.16m | 8.00 | -- | 1.69 | -- | -- | -0.441 | -0.441 | 0.00 | 0.2524 | 0.00 | -- | -- | 0.00 | -90.28 | -- | -104.75 | -- | -- | -- | -- | -- | -- | -49.56 | 0.1527 | -- | -- | -- | -112.71 | -- | -- | -- |
Intelligent Bio Solutions Inc | 2.83m | -10.03m | 7.18m | 17.00 | -- | 0.6033 | -- | 2.54 | -64.14 | -64.14 | 4.60 | 3.82 | 0.2041 | 2.69 | 7.77 | 166,299.40 | -72.67 | -80.65 | -107.67 | -224.84 | 23.33 | -- | -356.09 | -948.54 | 1.87 | -- | 0.0451 | -- | 187.51 | 367.97 | -28.00 | -- | -- | -- |
Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 7.27m | 389.00 | 0.0013 | 0.0001 | 0.7877 | 0.1276 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
Notable Labs Ltd | 311.00k | -12.39m | 7.30m | 16.00 | -- | 0.6327 | -- | 23.49 | -2.31 | -2.31 | 0.0622 | 1.28 | 0.0142 | -- | -- | 19,437.50 | -56.70 | -52.02 | -74.10 | -62.09 | 37.30 | 60.19 | -3,984.24 | -3,636.93 | -- | -- | 0.0271 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
Protagenic Therapeutics Inc | 0.00 | -6.01m | 7.41m | -- | -- | 3.47 | -- | -- | -1.37 | -1.37 | 0.00 | 0.4808 | 0.00 | -- | -- | -- | -117.26 | -74.49 | -140.56 | -92.56 | -- | -- | -- | -- | -- | -11.50 | 0.00 | -- | -- | -- | -40.64 | -- | -- | -- |
NuCana PLC (ADR) | 0.00 | -33.78m | 7.44m | 25.00 | -- | -- | -- | -- | -301.88 | -301.88 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -72.34 | -41.01 | -125.17 | -48.07 | -- | -- | -- | -- | -- | -- | 0.0324 | -- | -- | -- | 13.71 | -- | -21.70 | -- |
Trevena Inc | 3.14m | -40.15m | 7.65m | 23.00 | -- | -- | -- | 2.44 | -2.71 | -2.71 | 0.2107 | -0.7999 | 0.0904 | -- | -- | 136,478.30 | -115.65 | -55.93 | -148.14 | -66.35 | 48.04 | -- | -1,279.01 | -3,134.41 | -- | -15.39 | 1.88 | -- | 847.61 | -11.43 | 24.93 | -- | -24.67 | -- |
National Graphite Corp | 0.00 | -1.97m | 7.72m | 0.00 | -- | -- | -- | -- | -0.0221 | -0.0221 | 0.00 | -0.0193 | 0.00 | -- | -- | -- | -11,014.44 | -212.13 | -- | -6,295.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1,432.70 | -- | -- | -- |
Entero Therapeutics Inc | 0.00 | -6.44m | 7.76m | 15.00 | -- | 0.3529 | -- | -- | -51.90 | -51.90 | 0.00 | 38.45 | 0.00 | -- | -- | 0.00 | -12.74 | -295.92 | -14.01 | -1,599.51 | -- | -- | -- | -- | -- | -265.69 | 0.0802 | -- | -- | -- | -7.55 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Squarepoint OPS LLCas of 31 Mar 2024 | 63.70k | 0.71% |
Mariner LLCas of 31 Mar 2024 | 22.00k | 0.24% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 19.30k | 0.21% |
Two Sigma Securities LLCas of 31 Mar 2024 | 14.44k | 0.16% |
XTX Markets LLCas of 31 Mar 2024 | 10.19k | 0.11% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 5.00k | 0.06% |
UBS Securities LLCas of 31 Mar 2024 | 3.93k | 0.04% |
Group One Trading LPas of 31 Mar 2024 | 1.27k | 0.01% |
Securities America Advisors, Inc.as of 31 Mar 2024 | 630.00 | 0.01% |
Harel Mutual Funds Ltd.as of 31 Mar 2024 | 314.00 | 0.00% |